Food and Drug Administration (FDA) has approved prescription to over-the-counter (OTC) switch for Sklice (ivermectin lotion 0.5%) a pediculicide indicated for treatment of head lice infestation in patients aged 6 months and older. The OTC formulation of Sklice will be supplied in a single-use 117g tube; each gram of lotion contains 5mg of ivermectin, the same as the prescription strength. The product is for topical use only and should be used in the context of an overall lice management program. Sklice will no longer be available as a prescription drug.
e-Pharmatimes- "Protecting Ideas, Advancing Healthcare: A Pharma Blog"